28.09.2022 • News

Corteva Buys Spanish Microbiological Expert

US agricultural company Corteva, which combines businesses formerly belonging to DuPont, Dow and Pioneer, has agreed to buy Symborg, an expert in microbiological technologies based in Murcia, Spain. Financial terms were not disclosed.

© Shutterstock/ Pressmaster
© Shutterstock/ Pressmaster

The companies are already working together, with Corteva having been previously appointed as exclusive distributor for Symborg’s BlueN and Utrisha nitrogen nutrient-efficiency optimizers. In March this year, the agreement was expanded to include a nitrogen-fixation product.

“Acquiring Symborg is a significant next step in Corteva’s strategy to accelerate the development of a best-in-class biologicals portfolio, as a valuable part of our integrated solutions we offer to our customers,” said Robert King, executive vice president of Corteva Agriscience’s crop protection business.

Over the past three years, King said, “Corteva has established licensing and distribution agreements with the top biological companies, which we selected after evaluating technologies and demonstrating customer acceptance. This acquisition shows Corteva’s progression towards further establishing itself as a technology leader in this rapid growth segment.”

Corteva said it will leverage the combined organizations to scale up Symborg’s current biological products, as well as new ones in development.

Closing of the acquisition is subject to the usual conditions. Following completion, Symborg’s sites in Murcia and its subsidiaries in the US, Mexico, Peru, Chile, Brazil, France, Turkey, China and Australia will become part of Corteva’s biologicals portfolio.

Author: Elaine Burridge, Freelance Journalist

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.